Qingdao Haier Biomedical Co Ltd (688139) — Capital Reinvestment Ratio
Qingdao Haier Biomedical Co Ltd (688139) has a Capital Reinvestment Ratio of 7.36x as of June 2023, meaning it reinvests 7% of its operating cash flow (CN¥7.33 Million) in capital expenditures (CN¥53.93 Million). See Qingdao Haier Biomedical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Haier Biomedical Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Qingdao Haier Biomedical Co Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Qingdao Haier Biomedical Co Ltd from 2016 to 2025. For live market cap and broader valuation context, see Qingdao Haier Biomedical Co Ltd (688139) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥267.89 Million | CN¥119.25 Million | ▲ +2.5% |
| 2024 | 0.43x | CN¥291.67 Million | CN¥126.70 Million | ▼ -38.9% |
| 2023 | 0.71x | CN¥249.26 Million | CN¥177.18 Million | ▲ +52.8% |
| 2022 | 0.47x | CN¥632.43 Million | CN¥294.24 Million | ▲ +43.8% |
| 2021 | 0.32x | CN¥632.43 Million | CN¥204.69 Million | ▲ +153.4% |
| 2020 | 0.13x | CN¥696.62 Million | CN¥88.99 Million | ▼ -78.7% |
| 2019 | 0.60x | CN¥280.49 Million | CN¥168.40 Million | ▲ +29.0% |
| 2018 | 0.47x | CN¥149.00 Million | CN¥69.33 Million | ▲ +155.8% |
| 2017 | 0.18x | CN¥148.32 Million | CN¥26.98 Million | ▲ +176.8% |
| 2016 | 0.07x | CN¥220.72 Million | CN¥14.50 Million | — |